Browse > Article

Polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene in Kawasaki disease  

Han, Mi Young (Department of Pediatrics, College of Medicine, Kyunghee University)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.6, 2007 , pp. 570-575 More about this Journal
Abstract
Purpose : To demonstrate genetic background of pathogenesis of Kawasaki disease (KD), I examined the genetic polymorphism of plasminogen activator inhibitor-1 (PAI-1) in KD patients. Methods : PCR-RFLP of PAI- 1 promotor gene was analyzed in 56 KD patients admitted to Kyunghee University Hospital, Gachon Medical School Gil Hospital, and Eulji Hospital from March to August 2000 and 206 normal control populations. Results : There were no differences in the genotype and allelic frequency of the PAI-1-675 (4G/5G) and PAI-1-844 (G/A) polymorphic site (which are located in the promoter region) between KD and control subjects. Also I could not detect any significant differences in specific genotypes between patients with the coronary artery lesion (CAL) and patients without CAL. Conclusion : No association was observed in -844 G/A and -675 4G/5G of PAI-1 gene polymorphism with KD.
Keywords
Kawasaki disease; Genetic Polymorphsm; Plasminogen activator inhibitor;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, et al. HLA antigens in Kawasaki disease. Pediatrics 1978; 61:252-5
2 Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNFalpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003;102:147-50
3 Lindholt JS, Jorgensen B, Shi GP, Henneberg EW. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. Eur J vasc Endovasc Surg 2003;25:546-51   DOI   ScienceOn
4 Eriksson P, Kallin B, van't Hooft F, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen- activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851-5   DOI
5 Hindorff LA, Schwartz SM, Siscovick DS, Psaty BM, Longstreth WT, Reiner AP, et al. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovascular Risk 2002;9:131-7   DOI   ScienceOn
6 Chow KM, Szeto CC, Szeto CY, Poon P, Lai FM, Li PK. Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients. Transplantation 2002;74:1791-4
7 Senzaki H, Kobayashi T, Nagasaka H, Nakano H, Kyo S, Yokote Y, et al. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr Res 2003;53:983-8   DOI   ScienceOn
8 MacSweeney ST. Mechanical properties of abdominal aortic aneurysm and prediction of risk of rupture. Cardiovasc Surg 1999;7:158-9   DOI   ScienceOn
9 Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, et al. Circulating matrix metalloproteinases and their inhibitor in patients with Kawasaki disease. Circulation 2001;104:860-3   DOI
10 Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed MA. Diagnosis and therapy of Kawasaki disease. Circulation 1993;87:1776-80   DOI   ScienceOn
11 Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K, Johnsen M. Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice. Oncogene 2003;22:4389-97   DOI   ScienceOn
12 Ahn SY, Jang GC, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003;44: 1021-6   DOI
13 Bottiger C, Koch W, Lahn C, Mehilli J, von Beckerath N, Schomig A, et al. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. Am Heart J 2003;146:855-61   DOI   ScienceOn
14 Takeshita S, Tokutomi T, Kawase H, Nakatani K, Tsujimoto H, Kawamura Y, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin & Exp Immunol 2001;125:340-4   DOI
15 Mori M, Miyamae T, Kurosawa R, Yokota S, Onoki H. Two-generation Kawasaki disease: Mother and daughter. J Pediatrics 2001;139:754-6
16 Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the committee on rheumatic Fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 1994;89:916-22   DOI   ScienceOn
17 Kim HS. Effects of Chungshimgunbi-tang on the expressions of tissue factor and the plasminogen activator inhibitor-1 gene (dissertation) Seoul: Univ. Kyunghee, 1998
18 Sohn MH, Hur MW, Kim DS. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2001;2:357-62   DOI